A detailed history of First Republic Investment Management, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, First Republic Investment Management, Inc. holds 229,161 shares of AZN stock, worth $14.8 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
229,161
Previous 233,445 1.84%
Holding current value
$14.8 Million
Previous $16.7 Million 7.12%
% of portfolio
0.04%
Previous 0.09%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023

SELL
$64.85 - $71.7 $277,817 - $307,162
-4,284 Reduced 1.84%
229,161 $15.5 Million
Q2 2023

Jul 28, 2023

SELL
$69.91 - $75.81 $6.72 Million - $7.28 Million
-96,073 Reduced 29.16%
233,445 $16.7 Million
Q1 2023

May 11, 2023

BUY
$63.15 - $71.6 $25,133 - $28,496
398 Added 0.12%
329,518 $22.9 Million
Q4 2022

Feb 13, 2023

SELL
$54.21 - $70.44 $2.89 Million - $3.76 Million
-53,312 Reduced 13.94%
329,120 $22.3 Million
Q3 2022

Nov 03, 2022

BUY
$53.02 - $135.75 $9.94 Million - $25.5 Million
187,563 Added 96.25%
382,432 $21 Million
Q2 2022

Aug 16, 2022

BUY
$59.26 - $71.14 $3.85 Million - $4.62 Million
64,969 Added 50.01%
194,869 $12.9 Million
Q1 2022

May 16, 2022

BUY
$55.72 - $67.12 $277,708 - $334,526
4,984 Added 3.99%
129,900 $8.62 Million
Q4 2021

Feb 09, 2022

SELL
$54.02 - $63.83 $436,805 - $516,129
-8,086 Reduced 6.08%
124,916 $7.28 Million
Q3 2021

Nov 12, 2021

BUY
$55.56 - $60.79 $1.77 Million - $1.94 Million
31,896 Added 31.55%
133,002 $7.99 Million
Q2 2021

Aug 16, 2021

BUY
$48.42 - $60.18 $562,253 - $698,810
11,612 Added 12.98%
101,106 $6.06 Million
Q1 2021

May 14, 2021

SELL
$47.16 - $54.44 $547,056 - $631,504
-11,600 Reduced 11.47%
89,494 $4.45 Million
Q4 2020

Feb 16, 2021

BUY
$48.52 - $58.02 $236,437 - $282,731
4,873 Added 5.06%
101,094 $5.05 Million
Q3 2020

Nov 12, 2020

BUY
$53.07 - $61.1 $1.82 Million - $2.09 Million
34,204 Added 55.15%
96,221 $5.27 Million
Q2 2020

Aug 13, 2020

BUY
$43.1 - $55.31 $704,081 - $903,544
16,336 Added 35.76%
62,017 $3.28 Million
Q1 2020

May 13, 2020

SELL
$37.79 - $51.33 $152,369 - $206,962
-4,032 Reduced 8.11%
45,681 $2.04 Million
Q4 2019

Feb 14, 2020

SELL
$42.46 - $50.46 $277,858 - $330,210
-6,544 Reduced 11.63%
49,713 $2.48 Million
Q3 2019

Nov 08, 2019

SELL
$40.12 - $45.47 $12,156 - $13,777
-303 Reduced 0.54%
56,257 $2.51 Million
Q2 2019

Aug 07, 2019

SELL
$37.28 - $41.68 $1.03 Million - $1.15 Million
-27,500 Reduced 32.71%
56,560 $2.34 Million
Q1 2019

Apr 30, 2019

BUY
$35.49 - $43.02 $448,061 - $543,127
12,625 Added 17.67%
84,060 $3.4 Million
Q4 2018

Feb 12, 2019

BUY
$36.86 - $41.49 $27,718 - $31,200
752 Added 1.06%
71,435 $2.71 Million
Q3 2018

Nov 13, 2018

SELL
$34.76 - $39.72 $59,752 - $68,278
-1,719 Reduced 2.37%
70,683 $2.8 Million
Q2 2018

Aug 14, 2018

BUY
$34.55 - $37.05 $476,859 - $511,364
13,802 Added 23.55%
72,402 $2.54 Million
Q1 2018

May 10, 2018

BUY
$32.97 - $36.63 $91,491 - $101,648
2,775 Added 4.97%
58,600 $2.05 Million
Q4 2017

Feb 09, 2018

BUY
$32.09 - $34.78 $221,709 - $240,295
6,909 Added 14.12%
55,825 $1.94 Million
Q3 2017

Nov 14, 2017

BUY
$28.96 - $34.0 $1.42 Million - $1.66 Million
48,916
48,916 $1.66 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $200B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track First Republic Investment Management, Inc. Portfolio

Follow First Republic Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.